Research progress in imaging agents targeting Aβ and Tau protein in Alzheimer's disease / 中华核医学与分子影像杂志
Chinese Journal of Nuclear Medicine and Molecular Imaging
;
(6): 291-294, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-708866
ABSTRACT
Alzheimer's disease (AD) is a neurodegenerative disease,which is insidious onset and progressive.The pathological features of AD include senile plaques composed of amyloid β (Aβ) and neurofibrillary tangles composed of Tau protein.Aβ and Tau protein targeted imaging agents,which make a non-invasive and high specificity diagnosis,might be useful for early diagnosis,efficacy monitoring and drug evaluation for AD.This review summarizes the progress and clinical applications of those agents in AD.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio de tamizaje
Idioma:
Chino
Revista:
Chinese Journal of Nuclear Medicine and Molecular Imaging
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS